ETR:HNL Dr. Hönle (HNL) Stock Price, News & Analysis €9.44 0.00 (0.00%) As of 07/4/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Dr. Hönle Stock (ETR:HNL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Dr. Hönle alerts:Sign Up Key Stats Today's Range€9.26▼€9.4450-Day Range€8.26▼€11.4552-Week Range€11.00▼€20.30Volume339 shsAverage VolumeN/AMarket Capitalization€56.26 millionP/E RatioN/ADividend Yield2.12%Price TargetN/AConsensus RatingN/A Company Overview Dr. Hönle AG engages in the supply of industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, automotive, optics and opto-electronics, medical technology, and glass processing. The Equipment & Systems segment engages in the provision of solutions used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany. Read More Receive HNL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Hönle and its competitors with MarketBeat's FREE daily newsletter. Email Address HNL Stock News HeadlinesDr. Hönle AG (HNL.DE) - Yahoo FinanceJune 28, 2025 | sg.finance.yahoo.comDr. Hoenle AGJune 24, 2025 | barrons.comYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.July 7 at 2:00 AM | Priority Gold (Ad)Are Investors Undervaluing Dr. Hönle AG (ETR:HNL) By 33%?June 20, 2025 | finance.yahoo.comIs It Time To Consider Buying Dr. Hönle AG (ETR:HNL)?May 30, 2025 | finance.yahoo.comDr. Hönle Second Quarter 2025 Earnings: Beats ExpectationsMay 10, 2025 | uk.finance.yahoo.comThe past three years for Dr. Hönle (ETR:HNL) investors has not been profitableMarch 25, 2025 | finance.yahoo.comDr. Hoenle AG O.N.March 15, 2025 | de.investing.comSee More Headlines HNL Stock Analysis - Frequently Asked Questions How have HNL shares performed this year? Dr. Hönle's stock was trading at €7.56 on January 1st, 2025. Since then, HNL stock has increased by 24.9% and is now trading at €9.44. What other stocks do shareholders of Dr. Hönle own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dr. Hönle investors own include D.R. Horton (DHI), Dr Pepper Snapple Group (DPS), Meta Platforms (META), Marathon Digital (MARA), Grayscale Future of Finance ETF (GFOF), BNY Mellon Strategic Municipal Bond Fund (DSM) and Dr. Ing. h.c. F. Porsche (DRPRF). Industry, Sector and Symbol Stock ExchangeETR SectorIndustrials Industry Electrical Equipment & Parts Sub-IndustryN/A Current SymbolETR:HNL CIKN/A Webwww.hoenle.de Phone49 89 85608 0FaxN/AEmployees581Year FoundedN/AProfitability EPS (Trailing Twelve Months)(€2.23) Trailing P/E RatioN/A Forward P/E Ratio6.60 P/E Growth-0.39Net Income-€13.05 million Net Margins-13.44% Pretax MarginN/A Return on Equity-14.76% Return on Assets4.56% Debt Debt-to-Equity Ratio67.04 Current Ratio1.92 Quick Ratio0.85 Sales & Book Value Annual Sales€97.06 million Price / Sales0.58 Cash Flow€0.48 per share Price / Cash Flow19.54 Book Value€13.15 per share Price / Book0.72Miscellaneous Outstanding Shares5,959,328Free FloatN/AMarket Cap€56.26 million OptionableNot Optionable Beta1.45 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (ETR:HNL) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Hönle AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Hönle With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
